Tailored assay development focused on specific biological targets, disease pathways, or cellular phenotypes.

Expertise across biochemical and cellular assays.

Designed to support screening campaigns across a broad range of therapeutic modalities, including small molecules, biologics, nucleic acid based agents and emerging drug classes.

Automated liquid handling systems to enable high throughput dispensing and flexible automation workflows, ideal for screening applications across diverse assay formats

Miniaturised and scalable formats (96-, 384-, 1536-well) to enable cost-efficient hit discovery.

Broad portfolio of functional cellular assays including cell proliferation, viability, reporter gene expression, and cytokine profiling.

Biochemical formats include enzyme activity, protein-protein interactions, and receptor-ligand binding.

Customisable systems for disease-relevant models including oncology, inflammation, neurodegeneration, and infectious disease.

Expertise in precise genome modification using CRISPR/Cas9 and related systems, enabling targeted knockouts, knock-ins, and site-specific point mutations.

Custom-engineered cell lines, organoids, or model systems tailored to reflect disease-relevant genotypes, resistance mechanisms, or therapeutic targets.